Back to Search
Start Over
Anti-CD19 CAR T-Cell (CNCT19) Infusion Following HDT/ASCT Is Safe and Effective in Patients with Relapsed/Refractory Large B-Cell Lymphoma
- Source :
- Blood; November 2020, Vol. 136 Issue: Supplement 1 p2-2, 1p
- Publication Year :
- 2020
-
Abstract
- Lv: Juventas Cell Therapy Ltd.: Current Employment.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 136
- Issue :
- Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs54554930
- Full Text :
- https://doi.org/10.1182/blood-2020-139351